Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anastasiya Kuzyaeva"'
Autor:
Asiyat Radzhabova, Ekaterina Motyko, Lubov Polushkina, Marina Zenina, Anastasiya Kuzyaeva, Irina Martynkevich, Sergey Voloshin
Publikováno v:
HemaSphere, Vol 7, p e976297e (2023)
Externí odkaz:
https://doaj.org/article/7dcfb5f6fb3346b4b40378d7195cbba3
Autor:
Andrei Garifullin, Sergey Voloshin, Sergey Linnikov, Anastasiya Kuzyaeva, Alexander Schmidt, Marina Zenina, Alexandra Selcer, Valentina Balashova, Zanna Chubukina, Nataliya Alekseeva, Sergey Sidorkevich
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S183
Autor:
Sergey Linnikov, Zanna Chebukina, Georgiy Rysev, Anastasiya Kuzyaeva, Alexander Chechetkin, Valentina Balashova, Sergei Voloshin, Vasily Shuvaev, Andrey Garifullin
Publikováno v:
Blood. 136:5-6
Background: Bone marrow (peripheral blood stem cells (PBSCs)) autologous transplantation is the standard care for transplant-eligible patients with multiple myeloma. This treatment option is somewhat limited due to the high consumption of economic re
Autor:
Vasily Shuvaev, Sergey Linnikov, Alexander Sсhmidt, Alexey Kuvshinov, Anastasiya Kuzyaeva, Elizaveta Kleina, Zhanna Chubukina, Irina Martynkevich, Andrey Garifullin, Marina Bakai, Sergei Voloshin
Publikováno v:
Blood. 136:42-42
Assessment of the role of genetic abnormalities and minimal residual disease (MRD) is an active developing area in hematology. The use of genetic methods makes it possible to predict the course of the disease and apply an individualized approach to a
Autor:
Anastasiya Kuzyaeva, Alexander Sсhmidt, Alexander Chechetkin, Stanislav Bessmeltcev, Irina Martynkevich, Alexey Kuvshinov, Vasily Shuvaev, Sergei Voloshin, Irina Pavlova, Andrey Garifullin, Elizaveta Kleina
Publikováno v:
Blood. 134:5593-5593
Background The risk-stratification systems are repeatedly updated in accordance with the emergence of new information about the prognostic impact of anomalies and other factors. The most extensive and modern system in this time is mSMART risk stratif
Autor:
Alexander Schmidt, Elena Belyakova, Alexey Kuvshinov, Viktor Rugal, Anastasiya Kuzyaeva, Alexander Chechetkin, Georgiy Rysev, Valentina Balashova, Sergei Voloshin, Zhanna Chubukina, Andrey Garifullin, Vasily Shuvaev
Publikováno v:
Blood. 134:5636-5636
Background: High-dose chemotherapy (HDCT) followed by autologous transplantation of hematopoietic stem cells (auto-HSCT) is an important component of treatment in multiple myeloma (MM). There is a standard method of controlled cryopreservation of HSC